Esperas Pharma Inc.

Industry

  • Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • TVM Life Science Innovation I L.P
  • Fonds de solidarité FTQ
See more in Biomedtracker

Latest on Esperas Pharma Inc.

Scrip

Lilly Reacquires Aurora Kinase Inhibitor Via AurKa Buy For $110m

 
• By Mandy Jackson

Eli Lilly & Co. said on May 14 that it will pay $110m up front to buy AurKa Pharma Inc. in a deal that will bring the Aurora kinase inhibitor AK-01 back home to Lilly, which licensed the molecule t

In Vivo

Out Of The Blocks, May 2015

 
• By Nancy Dvorin

Admera Health 126 Corporate Boulevard South Plainfield, NJ 07080 Phone: (908) 222-0533 Email: clientcare@admerahealth.com Web Site: www.admerahealth.com Management: Steve Sun, PhD, CEO; Guanghui Hu,

In Vivo

Deals Shaping The Medical Industry, May 2015

IN VITRO DIAGNOSTICS Mergers & Acquisitions Rosetta Genomics Ltd. Prelude Corp. PersonalizeDx Rosetta Genomics Ltd. paid $2mm in cash and $1.5mm in stock (500k shares) to acquire private diagnosti

Scrip

Emergings In Brief, May 2015

 
• By Nancy Dvorin

Admera Health 126 Corporate Boulevard South Plainfield, NJ 07080 Phone: (908) 222-0533 Email: clientcare@admerahealth.com Web Site: www.admerahealth.com Management: Steve Sun, PhD, CEO; Guanghui Hu,